Work

Abstract 4444: Desthiazolylmethyloxycarbonyl ritonavir is a candidate proteasome activator drug in breast cancer that down-regulates survivin and HER2

Year: 2010

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am10-4444

Authors: Monica Milani, Ranjana Mitra, Gautam Jha, Mariangellys Rodriguez, Zhijun Guo, Dennis Weller, Rory P. Remmel, David A. Potter

Institution: University of Minnesota

Language: English

Topic: Ubiquitin and proteasome pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2079970096

Cites:

Cited by:

Related to: 10